Export 4 results:
Autore [ Titolo] Tipo Anno Filtri: First Letter Of Title è N and Autore is Zauli, Giorgio [Clear All Filters]
The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL. Invest New Drugs 2012;30(2):810-8.
. NF-κB pathways in hematological malignancies. Cell Mol Life Sci 2014;71(11):2083-102.
. The non-genotoxic activator of the p53 pathway Nutlin-3 shifts the balance between E2F7 and E2F1 transcription factors in leukemic cells. Invest New Drugs 2013;31(2):458-60.
. The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells. Oncotarget 2015;6(19):17147-60.
.